ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1586

Defining Hand Arthritis In Systemic Lupus Erythematosus, From An Ultrasound, Magnetic Resonance Imaging and Antibody Status Perspective

Elisabeth M.A Ball1, Arthur Grey2, Ai Lyn Tan3, Eiji Fukuba4, Gunter Steiner5, Dennis McGonagle6, Aubrey Bell7 and Madeleine Rooney8, 1Rheumatology, Queens' University/Musgrave Park Hospital, Belfast, United Kingdom, 2Rheumatology, Musgrave Park Hospital, Belfast, United Kingdom, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 4Department of Radiology, Shimane University, Izuma, Japan, 5Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 6NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, 7Rheumatology Unit, Musgrave Park Hospital, Belfast, United Kingdom, 8Medicine, Queens University Belfast, Belfast, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: anti-CCP antibodies, arthritis management, Magnetic resonance imaging (MRI), systemic lupus erythematosus (SLE) and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects II: Central Nervous System Manifestations, Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Musculoskeletal involvement in systemic lupus erythematosus (SLE) is common but poorly characterised with only a few Magnetic Resonance Imaging (MRI) or ultrasound (US) studies to date published in lupus arthritis.   Erosive disease in SLE associated with rheumatoid factor (RF) or anti-CCP antibody (ACPA) is often referred to as ‘rhupus’ to indicate a mixture of the character of RA and lupus.  This study used MRI and US to investigate a cohort of hand and wrist SLE disease in comparison to RA and in respect to autoantibody status.  

Methods:

50 SLE patients (median (IQR) disease duration 15.5 (9,20) yrs) with joint symptoms and /or objective arthritis, and 40 RA patients (median disease duration 15 (5,23) yrs) had a detailed US scan (Grey-scale (GS) and Power Doppler (PD)) of  dominant hand and wrist as per standardised protocols. 34 of these SLE patients and 15 RA patients also had a contrast enhanced MRI of their hand which was scored according to the OMERACT RAMRIS system. Extended antibody analysis (which included the anti-RA33 antibody and ACPA) was performed.

Results:

There were no normal MRI examinations in the SLE group; 85% of MCP joints in lupus patients showed at least Grade 1 synovitis, compared to 76.7% of all RA MCP joints. All SLE wrist joints showed at least Grade 1 synovitis. 61.8% of those SLE patients had MRI determined MCP joint erosion compared to 100% of RA patients.  93.3% had at least one erosion at the wrist with erosions in 45% of the total number (n = 240) of SLE carpal bones.  The prevalence of extensor tenosynovitis on MRI at the wrist was greater in the SLE group (20.3%), than in the rheumatoid group (10.7%) (p = 0.05).

Anti-RA33 titres  correlated with SLE disease activity (SELENA SLEDAI) scores (p = 0.03) but in addition there was a strong negative correlation with total MRI MCP and total PIP bone oedema (p = 0.013 and p = 0.019 respectively).  Only five SLE patients fulfilled the criteria for ‘rhupus’ in that they had a positive ACPA or RF in the presence of erosive disease.

There was good correlation of MRI synovitis scores at the MCP joints with MCP ultrasound GS and PD (p = 0.003 and p < 0.001 respectively). There was excellent correlation of MRI and US wrist extensor tenosynovitis scores (p < 0.003)

Conclusion:

This is the largest study to date using MRI in lupus arthritis and the first study to combine US and MRI in the assessment of SLE patients. We have shown that erosive lupus arthritis is independent of RF or ACPA status, challenging the use of the term ‘Rhupus’ as the only manifestation of erosive arthritis in SLE. The negative association of bone oedema with anti-RA33 titres would suggest that those patients who have high titres are less likely to have more aggressive arthritis.  This association with a more favourable outcome has been reported before in RA but has not yet been studied in relation to lupus arthritis.

 

Patient

No.

ACPA

RF

Anti-RA33 (titre)

Total MCP erosion score on MRI (range 0-50)

Total Wrist erosion score on MRI (range 0- 100 )

Total Extensor

Tenosynovitis score on Ultrasound

(range 0- 18 )

Total MCP Bone Oedema (range 0-12)

89

+

–

– (10.2)

24

7

3

0

45

+

–

– (8.4)

0

1

3

0

59

+

–

– (9.5)

22

10

2

6

2

–

+

– (6.8)

n/a

n/a

0

0

3

–

+

– (3.2)

33

7

0

19

6

–

–

+ (28)

0

1

0

0

16

–

–

+ (52)

2

5

0

0

33

–

–

+ (82)

3

1

0

0

37

–

–

+(316)

2

8

0

0

39

–

–

+ (96.2)

0

4

0

0

41

–

–

+ (83.7)

n/a

n/a

0

n/a

42

–

–

+ (78.5)

n/a

n/a

0

n/a

67

–

–

+ (40)

14

12

3

0

‘+’, positive antibody test, ‘-‘ negative antibody test, n/a, non-applicable as patient did not have an MRI scan

 


Disclosure:

E. M. A. Ball,
None;

A. Grey,
None;

A. L. Tan,
None;

E. Fukuba,
None;

G. Steiner,
None;

D. McGonagle,
None;

A. Bell,
None;

M. Rooney,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/defining-hand-arthritis-in-systemic-lupus-erythematosus-from-an-ultrasound-magnetic-resonance-imaging-and-antibody-status-perspective/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology